
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Toyota Motor Europe to roll out smart EV charging through new partnerships - 2
4 DSLR Cameras for Amateurs in 2024 - 3
New ‘Cloud-9’ object could reveal the secrets of dark matter - 4
What is ‘Auld Lang Syne’? Why we sing this song at midnight on New Year’s Eve. - 5
AfD in Brandenburg takes back suit against the intelligence service
Finding the Universe of Workmanship: Individual Encounters in Imagination
Figure out how to Arrange a Fair Settlement with the Assistance of a Fender bender Legal counselor
The Main 20 Gaming Control center Ever
10 Work Valuable chances to Assist with supporting Your Advanced degree
Vietnam rethinks its flood strategy as climate change drives storms and devastation
Pick Your Favored kind of soup
Nature: 10 High priority Setting up camp Spots In Europe
Remain Cool and Solid: Top Summer Food sources for 2024
Private sector revives the climate disaster database Trump tried to squash













